Cleveland Leukemia Therapeutics

Neoproteomics Inc is a Cleveland-based company specializing in advanced proteomics research and development. With a focus on Japan, they offer a range of innovative solutions and technologies for protein analysis, including the identification and characterization of proteins, protein-protein interactions, and post-translational modifications. Utilizing cutting-edge techniques and state-of-the-art equipment, Neoproteomics Inc provides comprehensive proteomic services to academic institutions, pharmaceutical companies, and biotechnology firms. Their expertise in proteomics enables them to contribute to advancements in drug discovery, personalized medicine, and biomarker identification, making them a trusted partner in the field of proteomics research.Generated from the website

IBM, a global leader in technology and innovation, has a rich history of over a century dedicated to ensuring the success of each client. Their commitment to creating meaningful innovations that have a positive impact on the world sets them apart in the industry. With a focus on cutting-edge solutions and forward-thinking strategies, IBM in Cleveland continues to push boundaries and drive progress in the ever-evolving tech landscape. Their dedication to excellence and client satisfaction remains unwavering as they strive to shape a better future through their groundbreaking work. Generated from their website's infomation

Cell X Technologies, Inc, located in Cleveland, OH, is at the forefront of the cell processing revolution with its transformative Celligent™ platform. This innovative combination of robotics, imaging, and artificial intelligence empowers developers to create consistent, reproducible, and scalable GMP-compliant processes for cellular therapies, tissue engineering, and artificial organ applications. By harnessing cutting-edge technologies, Cell X unlocks the potential of imaging, data analysis, and machine learning to gain unprecedented insights into cell culture processes. The Celligent platform facilitates early identification of critical quality attributes, determination of replicable process parameters, and optimization of production steps through ongoing refinements driven by artificial intelligence. With a strong emphasis on automation and machine learning, Cell X ensures a comprehensive suite of features from sample preparation to cell culturing. This commitment to precise and reproducible results enhances safety, efficacy, and regulatory compliance, ultimately making advanced cell therapies more accessible to a global audience. Generated from the website content